Jan Krönke

23PUBLICATIONS
98CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyGene and molecular therapyMedical mycologyCatalysis and mechanisms of reactions
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Jul 29, 2026
A distinct CAR-T cell phenotype mediates therapeutic response at limited doses.

|Jul 16, 2026
Functional immune profiling translates T cell dynamics into predictive biomarkers for myeloma immunotherapy.

|Jun 25, 2026
Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial.

|Feb 17, 2026
The evolution to hepta-refractory myeloma involves sequential loss of CD38, BCMA and GPRC5D.

C Riedhammer, M Truger, H Lee

|Dec 16, 2025
A Facile Protocol for C(sp2)-C(sp3) Bond Formation Reactions Toward Functionalized E3 Ligase Ligands.

Anita Maksutova, Thomas M Geiger, Lorenzo Cianni

|Nov 26, 2025
The Histone Modifier KANSL2 Is an Actionable Biomarker in Multiple Myeloma.

Kaiting Jiang, Marieluise Kirchner, Frederik Herzberg

Pageof 4

Frequent Collaborators

8 joint publications

Ulrich Keller

5 joint publications

Hermann Einsele

5 joint publications

K Martin Kortüm

5 joint publications

Christian Steinebach